Skip to main content
California Medicine logoLink to California Medicine
. 1970 Dec;113(6):1–5.

Cyclophosphamide Therapy of Idiopathic Nephrosis

Carl M Grushkin, Richard N Fine, Eva Heuser, Ellin Lieberman
PMCID: PMC1501850  PMID: 5486515

Abstract

Thirty-three children with steroid-dependent or steroid-resistant idiopathic nephrosis were treated with a combination of cyclophosphamide and prednisone. Remission occurred in all 23 steroid-dependent patients and, at last report, 12 had gone without any medication for periods of from two months to 21 months without relapse. Remission occurred in five of ten steroid-resistant patients.

The renal biopsy findings in these patients demonstrate a correlation between the “minimal change” lesion and a positive response to cyclophosphamide.

Full text

PDF
1

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHASIS H., GOLDRING W., BALDWIN D. S. The effect of nitrogen mustard on renal manifestations of human glomerulonephritis. J Clin Invest. 1950 Jun;29(6):804–804. [PubMed] [Google Scholar]
  2. COLDBECK J. H. EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME. Med J Aust. 1963 Dec 14;2:987–989. [PubMed] [Google Scholar]
  3. Churg J., Habib R., White R. H. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970 Jun 20;760(1):1299–1302. doi: 10.1016/s0140-6736(70)91905-7. [DOI] [PubMed] [Google Scholar]
  4. Drummond K. N., Hillman D. A., Marchessault J. H., Feldman W. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings. Can Med Assoc J. 1968 Mar 16;98(11):524–531. [PMC free article] [PubMed] [Google Scholar]
  5. Etteldorf J. N., Roy S., 3rd, Summitt R. L., Sweeney M. J., Wall H. P., Berton W. M. Cyclophosphamide in the treatment of idiopathic lipoid nephrosis. J Pediatr. 1967 May;70(5):758–766. doi: 10.1016/s0022-3476(67)80327-5. [DOI] [PubMed] [Google Scholar]
  6. GOOD R. A., SMITH R. T., VERNIER R. L. Serious untoward reactions to therapy with cortisone and adrenocorticotropin in pediatric practice. II. Pediatrics. 1957 Feb;19(2):272–284. [PubMed] [Google Scholar]
  7. Grupe W. E., Heymann W. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. Am J Dis Child. 1966 Nov;112(5):448–458. doi: 10.1001/archpedi.1966.02090140120011. [DOI] [PubMed] [Google Scholar]
  8. Lieberman E., Heuser E., Gilchrist G. S., Donnell G. N., Landing B. H. Thrombosis, nephrosis, and corticosteroid therapy. J Pediatr. 1968 Sep;73(3):320–328. doi: 10.1016/s0022-3476(68)80107-6. [DOI] [PubMed] [Google Scholar]
  9. Meadow S. R., Weller R. O., Archibald R. W. Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome. Lancet. 1969 Oct 25;2(7626):876–878. doi: 10.1016/s0140-6736(69)92330-7. [DOI] [PubMed] [Google Scholar]
  10. Moncrieff M. W., White R. H., Oggs C. S., Cameron J. S. Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J. 1969 Mar 15;1(5645):666–671. doi: 10.1136/bmj.1.5645.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Northway J. D., McAdams A. J., Forristal J., West C. D. A "silent" phase of hypocomplementemic persistent nephritis detectable by reduced serum beta-1c-globulin levels. J Pediatr. 1969 Jan;74(1):28–38. doi: 10.1016/s0022-3476(69)80005-3. [DOI] [PubMed] [Google Scholar]
  12. Scheinman J. I., Stamler F. W. Cyclophosphamide and fatal varicella. J Pediatr. 1969 Jan;74(1):117–119. doi: 10.1016/s0022-3476(69)80018-1. [DOI] [PubMed] [Google Scholar]
  13. van Acker K. J., Hooft C. The influence of hormone treatment on the natural evolution of the idiopathic nephrotic syndrome in childhood. Acta Paediatr Scand. 1968 Nov;57(6):479–486. doi: 10.1111/j.1651-2227.1968.tb06966.x. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES